- Report
- July 2026
- 180 Pages
Global
From €4386EUR$4,750USD£3,705GBP
- Report
- May 2026
- 400 Pages
Global
From €4570EUR$4,949USD£3,860GBP
- Report
- April 2026
- 143 Pages
Global
From €3692EUR$3,999USD£3,119GBP
- Report
- August 2026
- 130 Pages
Global
From €4386EUR$4,750USD£3,705GBP
- Report
- August 2026
- 120 Pages
Global
From €4386EUR$4,750USD£3,705GBP
- Report
- August 2026
- 180 Pages
Global
From €3647EUR$3,950USD£3,081GBP
- Report
- January 2026
- 148 Pages
Global
From €3647EUR$3,950USD£3,081GBP
- Report
- December 2025
- 150 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- August 2026
- 160 Pages
Global
From €3065EUR$3,320USD£2,589GBP
€3832EUR$4,150USD£3,237GBP
- Report
- August 2026
- 160 Pages
Global
From €3065EUR$3,320USD£2,589GBP
€3832EUR$4,150USD£3,237GBP
- Report
- April 2026
- 160 Pages
Global
From €3065EUR$3,320USD£2,589GBP
€3832EUR$4,150USD£3,237GBP
- Report
- August 2026
- 160 Pages
Global
From €3065EUR$3,320USD£2,589GBP
€3832EUR$4,150USD£3,237GBP
- Report
- December 2025
- 150 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- October 2025
- 96 Pages
Global
From €4155EUR$4,500USD£3,510GBP
From €2308EUR$2,500USD£1,950GBP
- Report
- June 2024
- 257 Pages
Global
From €5330EUR$5,975USD£4,350GBP
- Report
- September 2023
- 135 Pages
Global
From €4155EUR$4,500USD£3,510GBP
- Report
- June 2022
- 135 Pages
Global
From €2077EUR$2,250USD£1,755GBP
- Report
- October 2025
- 100 Pages
Global
From €2770EUR$3,000USD£2,340GBP
- Book
- March 2021
- 400 Pages
From €152EUR$165USD£129GBP

The Autoimmune Disease market within the context of Allergy and Immunology is a rapidly growing field of medical research and treatment. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment for autoimmune diseases typically involves immunosuppressive drugs, which reduce the activity of the immune system, and biologics, which target specific parts of the immune system.
In recent years, the development of new treatments for autoimmune diseases has been a major focus of research and development in the Allergy and Immunology field. Companies in this market are focused on developing new treatments, such as monoclonal antibodies, small molecule drugs, and gene therapies. Examples of companies in this market include AbbVie, Amgen, Biogen, Celgene, Gilead, and Regeneron. Show Less Read more